Anlon Healthcare is currently trading at Rs. 141.50, up by 2.70 points or 1.95% from its previous closing of Rs. 138.80 on the BSE.

The scrip opened at Rs. 141.85 and has touched a high and low of Rs. 142.85 and Rs. 139.00 respectively. So far 26773 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 172.00 on 01-Dec-2025 and a 52 week low of Rs. 86.98 on 05-Sep-2025.

Last one week high and low of the scrip stood at Rs. 142.85 and Rs. 124.25 respectively. The current market cap of the company is Rs. 748.37 crore.

The promoters holding in the company stood at 52.68%, while Institutions and Non-Institutions held 4.92% and 42.40% respectively.

Anlon Healthcare has received approval from Board of Directors for acquisition of 1,11,00,000 Equity Shares constituting 63.98% of Equity Share Capital of Remember India Health Links (Target Company) from certain existing shareholders of the Target Company, for a consideration amount of Rs 5.38 crore, on such terms and conditions as specified in the share purchase agreement dated April 16, 2026 inter alia entered into with the Target Company. Upon completion of such acquisition, the Target Company will become a subsidiary of the Company.

The primary objective of the proposed acquisition is to transform itself from an API manufacturer to a complete pharmaceutical provider. Through this acquisition, the company will expand its presence across the pharmaceutical value chain by moving beyond drug substances (APIs) into finished dosage formulations (FDFs), while also gaining access to more than 30 dossiers relating to finished dosage formulations.

The impact of the proposed acquisition is expected to extend across operational, financial, and regulatory dimensions. In particular, it is expected to facilitate integration of quality control processes, strengthen its financial profile, and enhance its market positioning from a B2B ingredient supplier to a broader pharmaceutical and healthcare platform with presence in domestic and international retail and hospital markets.

Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets.